Provenance du réseau au premier degré de Vincenzo Schifano
Entité | Type d'entité | Industrie | |
---|---|---|---|
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Vincenzo Schifano via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
LimFlow SA
LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member | |
CorWave SA
CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Swallis Medical SAS
Swallis Medical SAS Miscellaneous Commercial ServicesCommercial Services Swallis Medical SAS engages in the provision of diagnostic and monitoring solutions for problem of swallowing disorders. The company was founded by Linda Nicolini in 2019 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services TreeFrog Therapeutics SAS provides stem cell treatment services. It offers its expertise to patients of heart failure, diabetes, traumatic injury, skin burns, dermatitis, Huntington, and Parkinson disease. The company was founded by Maxime Feyeux, Kevin Alessandri, Jean-Luc Treillou, Erwan Bezard, Laurent Cognet, and Pierre Nassoy and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member | |
Backbone SAS
Backbone SAS Medical SpecialtiesHealth Technology Backbone SAS is a venture capital and private equity firm. It specializes in investments in late venture companies, startups, buyouts, growth financing, leveraged buyouts, and buyins. The company was founded by Nazanine Sahami on March 25, 2015 and is headquartered in Le Bouscat, France. | Medical Specialties | Director/Board Member | |
MicroPEP Technologies SAS
MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member | |
APSI 3D SAS | Director/Board Member | ||
Sud Ouest Capital Risque Innovation SAS
Sud Ouest Capital Risque Innovation SAS Investment ManagersFinance Sud Ouest Capital Risque Innovation SAS invests in innovative companies established in the Aquitaine and Midi-Pyrénées regions. The fund invests in the range of €150,000 - €1 million per transaction and also makes co-investments. | Investment Managers | Chairman | |
IRDInov SAS
IRDInov SAS Financial ConglomeratesFinance IRDInov SAS functions as an investment holding French company. The private company is based in Paris, France. | Financial Conglomerates | Chairman | |
TELECOM DESIGN | Specialty Telecommunications | Director/Board Member | |
ffly4u SAS
ffly4u SAS Specialty TelecommunicationsCommunications Ffly4u SASU provides a low frequency localization services for mobile assets. It also offers services like movement, temperature, noise or opening detection in order to guarantee the integrity of sensitive assets. The company was founded by Pages Olivier in 2015 and is headquartered in Toulouse, France. | Specialty Telecommunications | Director/Board Member | |
SENSORION | Pharmaceuticals: Major | Director/Board Member | |
École Centrale Paris | College/University | Undergraduate Degree | |
FineHeart SA
FineHeart SA Pharmaceuticals: MajorHealth Technology FineHeart SA manufactures medical devices for cardiovascular space. It offers wirelessly powered and fully-implantable mechanical circulatory support device. The company was founded by Stéphane Garrigue and Philippe Ritter on January 13, 2010 and is headquartered in Pessac, France. | Pharmaceuticals: Major | Director/Board Member | |
BIOM'UP | Medical Specialties | Director/Board Member | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
POXEL | Pharmaceuticals: Major | Director/Board Member | |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member | |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | Medical Specialties | Director/Board Member | |
Bouygues Télécom Initiatives SASU
Bouygues Télécom Initiatives SASU Investment ManagersFinance Bouygues Telecom Initiatives SASU (BTI) is the corporate venture subsidiary of the mobile telecommunications company Bouygues Telecom SA, which is majority-owned by the diversified French group Bouygues SA (XP: EN), active in sectors including construction, road infrastructure, real estate development, media and telecommunications. BTI was established in 2008 and is located in Meudon. The firm has a strategic alliance with the Microsoft start-up support program IDEAS. Their fellow subsidiary e-lab Bouygues SA is the corporate research and development specialist for the Bouygues group, and focuses on strongly innovative startups primarily outside of the telecommunications sector. | Investment Managers | Private Equity Analyst | |
EnobraQ SAS
EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member | |
École Nationale Supérieure de Chimie de Paris | College/University | Undergraduate Degree | |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Director/Board Member | |
Société Coopérative Agricole Interface Céréales SCA
Société Coopérative Agricole Interface Céréales SCA Chemicals: AgriculturalProcess Industries Société Coopérative Agricole Interface Céréales SCA engages in the development of sustainable agriculture. It provides animal feeds, fertilizers, agricultural chemicals, and other farm supplies. The company was founded in December 2005 and is headquartered in Dreux, France. | Chemicals: Agricultural | Director/Board Member | |
INSEAD | College/University | Masters Business Admin | |
Institut National des Sciences Appliquées de Toulouse | College/University | Undergraduate Degree | |
Cryolog SA
Cryolog SA Packaged SoftwareTechnology Services Cryolog SA provides traceability software solutions. The company was founded by Renaud Vaillant in 2002 and is headquartered in Nantes, France. | Packaged Software | Director/Board Member | |
Corporation de l'École Polytechnique de Montréal | College/University | Graduate Degree | |
Arterial Remodelling Technologies SA
Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
LID Technologies SAS
LID Technologies SAS Electrical ProductsProducer Manufacturing LDL Technology SAS designs, manufactures and develops wireless embedded electronic systems. Its technologies include tire pressure monitoring systems, vehicle immobilization, keyless entry and start system, and body control units. The company was founded by Dominique Luce and Philippe Lefaure on June 30, 2004 and is headquartered in Ramonville-Saint-Agne, France. | Electrical Products | Director/Board Member | |
UroMems SAS
UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member | |
Guard Medical, Inc.
Guard Medical, Inc. Medical/Nursing ServicesHealth Services Guard Medical, Inc. creates products that aim to improve the quality of life for surgical patients. The company is based in Miami, FL and was founded by Machiel van der Leest, J. Frederick Cornhill, Laurence Lefebvre, Sang Lee. The company is behind NPseal, a negative pressure wound therapy dressing that is easy to use and does not require batteries or tubes. The dressing features a simple pinch pump that applies and maintains gentle negative pressure that may promote wound healing. Numerous peer-reviewed studies have demonstrated the utility of NPWT in reducing wound healing time. | Medical/Nursing Services | Director/Board Member | |
IRDI Capital Investissement SAS
IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital Investissement SAS(IRDI Capital) is an independent French regional venture capital/private equity firm which was established in 1981 by Alain Savary. The firm is headquartered in Toulouse. | Investment Managers | Private Equity Investor | |
IXO Private Equity SAS
IXO Private Equity SAS Investment ManagersFinance IXO Private Equity SAS (IXO-PE) is an independent France-based regional private equity firm which was founded in 2002. Headquartered in Toulouse with an office in Bordeaux, the firm was previously known as ICSO Gestion. Their culture emphasizes regional development and local employment creation. The firm manages FCPR limited partnership venture capital funds for institutions and FIP regional development funds for individual investors. IXO-PE's institutional clients include local collectivities, insurance companies and international corporations as well as regional, national and European banks. | Investment Managers | Private Equity Investor | |
PALUMED SA
PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
France | 48 |
Canada | 3 |
Etats-Unis | 2 |
Sectorielle
Health Technology | 21 |
Finance | 10 |
Consumer Services | 7 |
Commercial Services | 5 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 49 |
Private Equity Investor | 8 |
Chairman | 6 |
Undergraduate Degree | 3 |
Private Equity Analyst | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Vincenzo Schifano
- Connexions Sociétés